Stocktoria
Arcutis Biotherapeutics, Inc. ARQT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-01-31
Arcutis Biotherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 3,949,609 | $103.6M | 3.1% |
| BlackRock Finance, Inc. | 8,622,618 | $80.2M | 6.78% |
| CITADEL ADVISORS LLC | 1,268,614 | $33.3M | 1% |
| TWO SIGMA INVESTMENTS, LP | 663,877 | $17.4M | 0.52% |
| MILLENNIUM MANAGEMENT LLC | 564,072 | $14.8M | 0.44% |
| Point72 Asset Management, L.P. | 362,449 | $9.5M | 0.28% |
| AQR CAPITAL MANAGEMENT LLC | 330,324 | $8.7M | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 58,399 | $1.5M | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.